In the GSDME-OE SCLC tumors, the IL12RB1-IL12 pathway is activated, leading to the release of more active components of IL12, the activation of CD4 effector memory T cells, and stimulation of T cells to release IFN-γ. Here, IFNG is linked to small cell lung carcinoma.